Laboratorios Richmond Ownership
RICH Stock | ARS 933.50 19.00 1.99% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Laboratorios |
Laboratorios Stock Ownership Analysis
The company has Price/Earnings (P/E) ratio of 480.26. Laboratorios Richmond last dividend was issued on the 9th of May 2022. Laboratorios Richmond S.A.C.I.F. develops and manufactures pharmaceutical products for physicians, pharmacists, health institutions, and patients in Argentina and internationally. The company was founded in 1935 and is based in Buenos Aires, Argentina. LAB RICHMOND is traded on Buenos-Aires Stock Exchange in Argentina. To find out more about Laboratorios Richmond SACIF contact Juan Artola at 54 11 5555 1600 or learn more at https://www.richmondlab.com.Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Laboratorios Richmond SACIF. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Richmond's price analysis, check to measure Laboratorios Richmond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Richmond is operating at the current time. Most of Laboratorios Richmond's value examination focuses on studying past and present price action to predict the probability of Laboratorios Richmond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Richmond's price. Additionally, you may evaluate how the addition of Laboratorios Richmond to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |